Antibodies to intercellular adhesion molecule 1-binding Plasmodium falciparum erythrocyte membrane protein 1-DBLβ are biomarkers of protective immunity to malaria in a cohort of young children from Papua New Guinea
Version 3 2024-06-18, 17:39Version 3 2024-06-18, 17:39
Version 2 2024-06-05, 04:00Version 2 2024-06-05, 04:00
Version 1 2019-11-18, 15:46Version 1 2019-11-18, 15:46
journal contribution
posted on 2024-06-18, 17:39authored bySK Tessema, D Utama, O Chesnokov, AN Hodder, CS Lin, GLA Harrison, JS Jespersen, B Petersen, L Tavul, P Siba, D Kwiatkowski, T Lavstsen, DS Hansen, AV Oleinikov, I Mueller, Alyssa BarryAlyssa Barry
Plasmodium falciparum
erythrocyte membrane protein 1 (PfEMP1) mediates parasite sequestration to the cerebral microvasculature via binding of DBLβ domains to intercellular adhesion molecule 1 (ICAM1) and is associated with severe cerebral malaria. In a cohort of 187 young children from Papua New Guinea (PNG), we examined baseline levels of antibody to the ICAM1-binding PfEMP1 domain, DBLβ3
PF11_0521
, in comparison to four control antigens, including NTS-DBLα and CIDR1 domains from another group A variant and a group B/C variant.